Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HSD17B10 | Q99714 | 4/20 | 0.39 |
| ▸ | AKR1B1 | P15121 | 4/20 | 0.39 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.39 |
| ▸ | PTPN1 | P18031 | 3/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.39 |
| ▸ | AKR1B10 | O60218 | 2/20 | 0.39 |
| ▸ | TSHR | P16473 | 1/20 | 0.39 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.39 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.39 |
| ▸ | APP | P05067 | 1/20 | 0.39 |
| ▸ | PTPN2 | P17706 | 1/20 | 0.39 |
| ▸ | HDAC4 | P56524 | 1/20 | 0.39 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.39 |
| ▸ | HDAC7 | Q8WUI4 | 1/20 | 0.39 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.39 |
| ▸ | HDAC10 | Q969S8 | 1/20 | 0.39 |
| ▸ | HDAC11 | Q96DB2 | 1/20 | 0.39 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.39 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.39 |
| ▸ | HDAC9 | Q9UKV0 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Quinic Acid SCHEMBL12026338 | 1.00 | HSD17B10 (0.39) | HSD17B10AKR1B1KDM4EPTPN1ALDH1A1 | |
| Quinic Acid SCHEMBL10125264 | 1.00 | HSD17B10 (0.39) | HSD17B10AKR1B1KDM4EPTPN1ALDH1A1 | |
| Quinic Acid SCHEMBL6656460 | 1.00 | HSD17B10 (0.39) | HSD17B10AKR1B1KDM4EPTPN1ALDH1A1 | |
| Quinic Acid SCHEMBL39556 | 1.00 | HSD17B10 (0.39) | HSD17B10AKR1B1KDM4EPTPN1ALDH1A1 | |
| Quinic Acid SCHEMBL19490687 | 1.00 | HSD17B10 (0.39) | HSD17B10AKR1B1KDM4EPTPN1ALDH1A1 | |
| Quinic Acid SCHEMBL14960616 | 1.00 | HSD17B10 (0.39) | HSD17B10AKR1B1KDM4EPTPN1ALDH1A1 | |
| Quinic Acid SCHEMBL7923331 | 1.00 | HSD17B10 (0.39) | HSD17B10AKR1B1KDM4EPTPN1ALDH1A1 | |
| Quinic Acid SCHEMBL1286207 | 1.00 | HSD17B10 (0.39) | HSD17B10AKR1B1KDM4EPTPN1ALDH1A1 | |
| Quinic Acid SCHEMBL39555 | 1.00 | HSD17B10 (0.39) | HSD17B10AKR1B1KDM4EPTPN1ALDH1A1 | |
| Quinic Acid SCHEMBL12045452 | 1.00 | HSD17B10 (0.39) | HSD17B10AKR1B1KDM4EPTPN1ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 361 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11785961-B2 | Process for the production of a liquid coffee concentrate | KONINKLIJKE DOUWE EGBERTS B.V. (NL) | 2023-10-17 | — | — | US | claimed |
| WO-2022069013-A1 | MEDICINAL COMPOSITION FOR THE TREATMENT AND PREVENTION OF COVID-19 AND OTHER INFECTIONS AND CONDITIONS. NOVEL USES OF ALPHA-ACETOXYTOLUENE, BENZYL ALCOHOL AND BENZYL GROUPS FOR CONTROLLING THE COVID-19 PANDEMIC AND OTHER INFECTIONS AND CONDITIONS | OMAR BENCHERGUIA (DZ) | 2022-04-07 | — | — | WO | claimed |
| CN-109982724-A | Deodorant agent | 理研香料控股株式会社 | 2019-07-05 | — | — | CN | claimed |
| EP-1867729-A1 | Water soluble phenolics derivatives with dermocosmetic and therapeutic applications | Libragen (FR) | 2007-12-19 | — | — | EP | claimed |
| WO-2006084174-A2 | IMPROVED BIOAVAILABILITY AND IMPROVED DELIVERY OF ALKALINE PHARMACEUTICAL DRUGS | YU RUEY J (US) | 2006-08-10 | — | — | WO | claimed |
| US-20050196418-A1 | Bioavailability and improved delivery of alkaline pharmaceutical drugs | YU RUEY J (US) | 2005-09-08 | — | — | US | claimed |
| US-20050171194-A1 | Enlargement of mucocutaneous or cutaneous organs and sites with topical compositions | YU RUEY J (US) | 2005-08-04 | — | — | US | claimed |
| WO-2005055947-A2 | ENLARGEMENT OF MUCOCUTANEOUS OR CUTANEOUS ORGANS AND SITES WITH TOPICAL COMPOSITIONS | YU RUEY J (US) | 2005-06-23 | — | — | WO | claimed |
| US-20040214215-A1 | Bioavailability and improved delivery of alkaline pharmaceutical drugs | YU RUEY J (US) | 2004-10-28 | — | — | US | claimed |
| EP-1009398-A4 | MOLECULAR COMPLEX AND CONTROL-RELEASE OF ALPHA HYDROXYACIDS | YU RUEY J (US) | 2004-06-23 | — | — | EP | claimed |
| CN-1298279-A | Utilization of natural and/or synthetic quinic acid and/or precursors thereof as insect repellents | BIOCONNECTING TECH AG (CH) | 2001-06-06 | — | — | CN | claimed |
| EP-1009398-A1 | MOLECULAR COMPLEX AND CONTROL-RELEASE OF ALPHA HYDROXYACIDS | Yu, Ruey J., Dr. (US) | 2000-06-21 | — | — | EP | claimed |
| US-5877212-A | HYDROGEN BONDING WITH COMPLEXING AGENT | YU RUEY J (US) | 1999-03-02 | — | — | US | claimed |
| WO-1998046217-A1 | MOLECULAR COMPLEX AND CONTROL-RELEASE OF ALPHA HYDROXYACIDS | YU RUEY J (US) | 1998-10-22 | — | — | WO | claimed |
| EP-0667245-A1 | Recording sheets containing alcohols and saccharides | XEROX CORPORATION (US) | 1995-08-16 | — | — | EP | claimed |
| JP-2248931-A | — | — | None | — | — | JP | disclosed |
| EP-4727373-A1 | COMPOSITIONS AND USES THEREOF | Givaudan SA (CH) | 2026-04-22 | — | — | EP | disclosed |
| EP-0154491-A2 | Quinate salts of the antimalarial compound mefloquine | SMITHKLINE BEECHAM CORPORATION (US) | 1985-09-11 | — | — | EP | disclosed |
| US-4521424-A | Quinate salts of the antimalarial compound mefloquine | SMITHKLINE BECKMAN CORPORATION (US) | 1985-06-04 | — | — | US | disclosed |
| EP-0138374-A2 | Salts of antimalarial phenanthrenemethanol compounds | SMITHKLINE BECKMAN CORPORATION (US) | 1985-04-24 | — | — | EP | disclosed |